← FDA Drug Approvals (Drugs@FDA)
ICATIBANT ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2021-05-21
Drug application
- FDA Application #
ANDA213222- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ICATIBANT ACETATE
- Generic name
- Icatibant Acetate
- Active ingredients
- ICATIBANT ACETATE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- GLENMARK PHARMS LTD
- First approval
- 2021-05-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown